Oral contraceptive use and the risk of breast cancer

被引：31

作者：

Casey, Petra M. ^{[1
]}

Cerhan, James R. ^{[2
]}

Pruthi, Sandhya ^{[3
]}

机构：

[1] Mayo Clin, Dept Obstet & Gynecol, Rochester, MN 55905 USA

[2] Mayo Clin, Div Epidemiol, Rochester, MN 55905 USA

[3] Mayo Clin, Breast Diagnost Clin, Rochester, MN 55905 USA

来源：

MAYO CLINIC PROCEEDINGS | 2008年 / 83卷 / 01期

关键词：

D O I：

10.4065/83.1.86

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The clinical impact of the association between oral contraceptive (OC) use and breast cancer risk is important given that OCs are the most commonly prescribed contraceptive agent and that more than a quarter of a million women are diagnosed as having breast cancer in the United States annually. Substantial changes to OC formulations have been made during the past decade, and this review focuses on recent OC trends and risks and benefits. We also have a better understanding of how estrogen affects breast carcinogenesis; research on this topic is ongoing and has the goal of decreasing breast cancer incidence and mortality.

引用

页码：86 / 91

页数：6

共 50 条

[41] CHILDBEARING, ORAL-CONTRACEPTIVE USE, AND BREAST-CANCER
BERAL, V
REEVES, G
LANCET, 1993, 341 (8852): : 1102 - 1102
[42] ORAL-CONTRACEPTIVE USE AND BREAST-CANCER IN INDONESIA
BUSTAN, MN
COKER, AL
ADDY, CL
MACERA, CA
GREENE, F
SAMPOERNO, D
CONTRACEPTION, 1993, 47 (03) : 241 - 249
[43] Oral Contraceptive Use and Survival in Women with Invasive Breast Cancer
Lu, Yani
Ma, Huiyan
Malone, Kathleen E.
Norman, Sandra A.
Sullivan-Halley, Jane
Strom, Brian L.
Simon, Michael S.
Marchbanks, Polly A.
McDonald, Jill A.
West, Dee W.
Henderson, Katherine D.
Deapen, Dennis
Ursin, Giske
Bernstein, Leslie
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2011, 20 (07) : 1391 - 1397
[44] Timing of oral contraceptive use and the risk of breast cancer in BRCA1 mutation carriers
Joanne Kotsopoulos
Jan Lubinski
Pal Moller
Henry T. Lynch
Christian F. Singer
Charis Eng
Susan L. Neuhausen
Beth Karlan
Charmaine Kim-Sing
Tomasz Huzarski
Jacek Gronwald
Jeanna McCuaig
Leigha Senter
Nadine Tung
Parviz Ghadirian
Andrea Eisen
Dawna Gilchrist
Joanne L. Blum
Dana Zakalik
Tuya Pal
Ping Sun
Steven A. Narod
Breast Cancer Research and Treatment, 2014, 143 : 579 - 586
[45] Reproductive History and Oral Contraceptive Use in Relation to Risk of Triple-Negative Breast Cancer
Phipps, Amanda I.
Chlebowski, Rowan T.
Prentice, Ross
McTiernan, Anne
Wactawski-Wende, Jean
Kuller, Lewis H.
Adams-Campbell, Lucile L.
Lane, Dorothy
Stefanick, Marcia L.
Vitolins, Mara
Kabat, Geoffrey C.
Rohan, Thomas E.
Li, Christopher I.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (06): : 470 - 477
[46] Oral contraceptive use and risk of breast cancer: A meta-analysis of prospective cohort studies
Zhu, Hang
Lei, Xun
Feng, Jing
Wang, Yang
EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2012, 17 (06): : 402 - 414
[47] Timing of oral contraceptive use and the risk of breast cancer in BRCA1 mutation carriers
Kotsopoulos, Joanne
Lubinski, Jan
Moller, Pal
Lynch, Henry T.
Singer, Christian F.
Eng, Charis
Neuhausen, Susan L.
Karlan, Beth
Kim-Sing, Charmaine
Huzarski, Tomasz
Gronwald, Jacek
McCuaig, Jeanna
Senter, Leigha
Tung, Nadine
Ghadirian, Parviz
Eisen, Andrea
Gilchrist, Dawna
Blum, Joanne L.
Zakalik, Dana
Pal, Tuya
Sun, Ping
Narod, Steven A.
BREAST CANCER RESEARCH AND TREATMENT, 2014, 143 (03) : 579 - 586
[48] Oral contraceptive use and breast cancer risk in women aged 40 years or younger.
Ursin, G
Ross, RK
SullivanHalley, J
Hanisch, R
Bernstein, L
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1996, 143 (11) : 170 - 170
[49] Oral contraceptive use before first birth and risk of breast cancer: A case control study
Hemminki E.
Luostarinen T.
Pukkala E.
Apter D.
Hakulinen T.
BMC Women's Health, 2 (1)
[50] A PROSPECTIVE-STUDY OF ORAL-CONTRACEPTIVE USE AND THE RISK OF BREAST-CANCER IN WOMEN
ROMIEU, I
WILLETT, WC
COLDITZ, GA
STAMPFER, MJ
ROSNER, B
HENNEKENS, C
SPEIZER, FE
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1989, 130 (04) : 812 - 812

← 1 2 3 4 5 →